Study on teratogenic effects of methotrexate; Alteration of gene expression pattern in human placenta choriocarcinoma (JEG-3) cells

BioChip Journal - Tập 4 - Trang 189-196 - 2010
Jina Lee1, Youn-Jung Kim2, Jae-Chun Ryu1
1Cellular and Molecular Toxicology Laboratory, Korea Institute of Science & Technology, Cheongryang, Seoul, Korea
2Department of Applied Chemistry, Kyung Hee University, Yongin, Korea

Tóm tắt

Methotrexate is a well known chemotherapeutic agent, extensively used for leukemia and other cancers. Although its efficacy is wide, methotrexate can cause serious or life-threatening toxicities on liver, lungs, kidney, and immune system. Teratogenicity is one of the methotrexate-induced side effects. So, we performed with JEG-3, human placenta choriocarcinoma cell line, to identify the differentially expressed genes (DEGs) related to teratogenicity of methotrexate using an Agilent 44-K whole human genome chip. Through the analysis of gene expression profiles, we identified 887 up-regulated genes and 828 down-regulated genes above 1.5-fold by methotrexate. At IC30 doses recognized genes were functionally categorized as being involved in purine and pyrimidine biosynthetic process, cell cycle arrest, and apoptosis. Functionally important purine and pyrimidine biosynthesis-related genes were further validated by real-time RT-PCR. The results showed that GART, HPRT1, TYMS, and CTPS genes altered their expression levels by methotrexate. Alteration of these genes may lead to methotrexate-induced teratogenicity, which caused by imbalance of nucleotide biosynthesis. In conclusion, both gene expression profiles and functional analysis have identified potential gene-based biomarkers and provided insights into the mechanism underlying the response of human placenta cell line to methotrexate exposure.

Tài liệu tham khảo

Heena, T., Suhel, P., Syed, T.P., Basu, D.B. & Sheikh, R. Protective effect of lipoic acid against methotrexateinduced oxidative stress in liver mitochondria. Food Chem. Toxicol. 48, 1973–1979 (2010). Koyama, S. et al. Methotrexate stimulates lung epithelial cells to release inflammatory cell chemotactic activities. Exp. Lung. Res. 29, 91–111 (2003). Turesson, C. & Matteson, E.L. Genetics of rheumatoid arthritis. Mayo. Clin. Proc. 81, 94–101 (2006). Hsu, P.C., Lan, J.L., Hsieh, T.Y., Jan, Y.J. & Huang, W.N. Methotrexate pneumonitis in a patient with rheumatoid arthritis. J. Microbiol. Immunol. Infect. 36, 137–140 (2003). Premila, A., Viswa, K.K. & Suganthy, R. Melatonin attenuates methotrexate-induced oxidative stress and renal damage in rats. Cell Biochem. Funct. 28, 426–433 (2010). Djerassi, I. High-dose methotrexate and citrovorum factor rescue: background and rationale. Cancer Chemother Rep. 6, 3–6 (1975). Frei, R.D., Blum, R.H. & Pitman, S.W. High dose methotrexate with leucovorin rescue: rationale and spectrum of antitumor activity. Am. J. Med. 68, 370–376 (1980). Jahovic, N., Cevik, H., Sehirli, A.O., Yeğen, B.C. & Sener, G. Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats. J. Pineal. Res. 34, 282–287 (2003). Chakravarty, E.F., Sanchez-Yamamoto, D. & Bush, T.M. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: A survey of practice patterns and pregnancy outcomes. J. Rheumatol. 30, 241–246 (2003). Schuna, A.A. Update on treatment of rheumatoid arthritis. J. Am. Pharm. Assoc. 38, 728–735 (1998). Corona-Rivera, J.R. et al. Holoprosencephaly and genitourinary anomalies in fetal methotrexate syndrome. Am J. Med. Genet. A. 152A, 1741–1746 (2010). Vinson, R.K. & Hales, B.F. Expression and activity of the DNA repair enzyme uracil DNA glycosylase during organogenesis in the rat conceptus and following methotrexate exposure in vitro. Biochem. Pharmacol. 64, 711–721 (2002). Svirsky, R. et al. The safety of conception occurring shortly after methotrexate treatment of an ectopic pregnancy. Reprod. Toxicol. 27, 85–87 (2009). Kim, Y.J. et al. Differential gene expression induced by naphthalene in two human cell line, HepG2 and HL-60. Mol. Cell. Toxicol. 5, 99–107 (2009). Bae, H.J. et al. Decreased expression of the suppressor of cytokine signaling 6 in human hepatocellular carcinoma. Mol. Cell. Toxicol. 5, 193–197 (2009). Kim, Y.J., Lee, J. & Ryu, J.C. Altered gene expression and functions in thalidomide-treated human placenta choriocarcinoma (JEG-3) cells. BioChip J. 4, 22–29 (2010). Fukushima, R. Inhibiting the teratogenicity of the immunosuppressant leflunomide in mice by supplementation of exogenous uridine. Toxicol. Sci. 108, 419–426 (2009). Kobayashi, K., Matsumoto, K., Hoshino, Y. & Hayano, K. Teratogenic effects of a new immunosuppressive agent, bredinin, in the mouse. Teratology. 10, 87–88 (1974). Okamoto, K. et al. Teratogenic effects of bredinin, a new immunosuppressive agent, in rats. Congenit. Anom. 18, 227–233 (1978). Lynette, D. et al. Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis? Biochem J. 342, 143–152 (1999). Ya-Yuan, F. et al. Prostasin regulates human placental trophoblast cell proliferation via the epidermal growth factor receptor signaling pathway. Hum. Reprod. 25, 623–632 (2010). Benaitreau, D. et al. Antiproliferative effects of adiponectin on human trophoblastic cell lines JEG-3 and BeWo. Biol. Reprod. 80, 1107–1114 (2009). Aplin, J.D. & Kimber, S.J. Trophoblast-uterine interactions at implantation. Reprod. Biol. Endocrinol. 2, e48 (2004). Lunghi, L., Ferretti, M.E., Medici, S., Biondi, C. & Vesce, F. Control of human trophoblast function. Reprod. Biol. Endocrinol. 5, e6 (2007). Castro-Rendon, W.A., Castro-Alvarez, J.F., Guzman-Martinez, C. & Bueno-Sanchez, J.C. Blastocyst-endometrium interaction: intertwining a cytokine network. Braz. J. Med. Biol. Res. 39, 1373–1385 (2006). Mardon, H.J. et al. Hormonal and paracrine regulation of embryonic implantation: a workshop report. Placenta. 28suppl A, S82–S84 (2007). Campos, D.B., Palin, M.F., Bordignon, V. & Murphy, B.D. The ‘beneficial’ adipokines in reproduction and fertility. Int. J. Obes. (Lond). 32, 223–231 (2008). Kwok, J.B. & Tattersall, M.H. DNA fragmentation, dATP pool elevation and potentiation of antifolate cytotoxicity in L1210 cells by hypoxanthine. Br. J. Cancer 65, 503–508 (1992). Yoshioka, A. et al. Deoxyribonucleoside-triphosphate imbalance. 5-Fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death. J. Biol. Chem. 262, 8235–8241 (1987). Yasuhide, H. et al. Imbalance of deoxyribonucleoside triphosphates, DNA double-strand breaks, and cell death caused by 2-chlorodeoxyadenosine in mouse FM3A cells. Cancer Res. 49, 915–919 (1989). Jeffrey, L. et al. Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs. J. Nucl. Med. 44, 2027–2032 (2003).